Stocktoria

AtaiBeckley Inc. ATAI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-18 · LEI

AtaiBeckley Inc. financials (annual)

Revenue
$308000 $4.1M 20242025
Net income
-$149.3M -$660.0M 20242025
Free cash flow
-$82.4M -$103.6M 20242025

Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024
Revenue$4.1M$308,000
R&D expense$900,000
Operating income-$644.1M-$102.7M
Income tax$298,000-$356,000
Net income-$660.0M-$149.3M
EPS (diluted)$-2.91$-0.93
Operating cash flow-$102.7M-$82.4M
Free cash flow-$103.6M-$82.4M
Cash & equivalents$85.3M$17.5M
Total assets$292.7M$159.4M
Total liabilities$70.7M$42.8M
Shareholders' equity$222.0M$116.6M

Growth · year-over-year · Revenue CAGR 1227.6%

MetricFY2025FY2024
Revenue growth+1227.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.